Light Mode
$20.32 ↑ +0.00 (+0.00%) Trading Up from the previous close of $20.32, $0.03 below the day’s high of $20.35
-2.35 (-10.37%) / 6M
Momentum, market sentiment, and recent alerts
ACAD reads neutral: price sits above one of the two key moving averages, the 12-month move is -10.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.